Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 21Terminated 7Recruiting 6Unknown 4Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1

Conditions

Influenza, Human 2Serology Analysis 1Neoplasms 1Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × Influenza Vaccines × Clear all
NCT04221971 2020-10-01

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Peking University People's Hospital

Phase 1 Unknown
10 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04355806 2020-04-21

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Shanghai Pulmonary Hospital, Shanghai, China

Unknown
160 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Influenza, Human

NCT01698177 2013-04-19

Optimizing Influenza Vaccination in Surgical Oncology Patients

Stony Brook University

Phase 4 Unknown
204 enrolled

Influenza, Human, Neoplasms

NCT01046227 2010-01-11

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

National Taiwan University Hospital

Unknown
50 enrolled

Serology Analysis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡